Strengthening Indonesia's HIV response: HCPI provides access to care for injecting drug users
Last month marked the closure of the Australian Aid funded eight-year HIV Cooperation Program for Indonesia (HCPI), one of the main components of the Australia-Indonesia Partnership for HIV (AIPH). To celebrate HCPI’s legacy of positive impact, we are releasing a series of stories, each exploring key program components and achievements.
Providing access to comprehensive care for People Who Inject Drugs
The initial challenge for HCPI and people who inject drugs (PWID) was to develop access to prevention services in areas with the highest rates of injecting drug users (IDU). These programs were then expanded to ensure that PWID could access a comprehensive range of HIV services. At program closure, HCPI had been particularly successful in needle syringe and education programs, opioid replacement therapy for heroin users, and increased access to HIV treatment services for IDUs.
During implementation, HCPI built a strong network of partners in nine provinces across Indonesia and supported 76 Community Health Centres (CHC), three hospitals and 18 Community-Based Organisations (CBO) to provide needle syringe programs (NSP). At the peak of heroin availability in 2013, HCPI supported health partners distributed more than 1.8 million needle syringes to PWID. Access to anti-retroviral therapy (ART) was also a key focus for working with PWIDs. Part of this ART approach included a mapping exercise carried out by HCPI with the Jakarta Provincial Health Office to identify appropriate hospitals and CHCs to scale up ART.
Download the PWID Overview to learn more about HCPI’s work in providing access to comprehensive care for PWID in Indonesia.
HCPI has played a key role in the country's response to HIV. The eight year program partnered with the National AIDS Commission, Provincial AIDS Commissions, local health offices and civil society, to support Indonesia in planning, developing and implementing an effective and sustainable response to HIV in all provinces in Java, Bali, and Papua and West Papua. HCPI has also worked to foster leadership within government and civil society to address HIV and AIDS. While the closing of HCPI at the end of June marked the end of the Australian Government’s current long-term investment in strengthening Indonesia’s response to HIV and AIDS through a comprehensive bilateral program, it will maintain support to HIV and AIDS in Indonesia including through its ongoing involvement with the Global Fund and research in HIV treatment.
For more information about HCPI and its legacy of positive impact, please contact Jane Daniels, Palladium APAC Health Practice Director (Jane.Daniels@thepalladiumgroup.com).